Urol. praxi. 2022;23(4):192-195 | DOI: 10.36290/uro.2022.050

Pharmacology support of bladder urothelium function restoration

PharmDr. Bc. Hana Kotolová, Ph.D.
Ústav farmakologie a toxikologie, Farmaceutická fakulta, Masarykova univerzita Brno

Incidence of urinary tract infections in clinical practice is hight. Urinary tract infections represent together with respirátory infections the most common inflammatory disease. In terms of currant situation og antibiotic resistence also antibiotic resistance also nonantibiotic strategyes of treatment are recommended. One option is to use complex effect of hyaluronic acid, chondroitinsulfate, quercetin and curcumin on support of bladder urothelium function restoration.

Keywords: hyaluronic acid, chondroitinsulfate, quercetin, curcumin.

Accepted: November 23, 2022; Published: December 5, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotolová H. Pharmacology support of bladder urothelium function restoration. Urol. praxi. 2022;23(4):192-195. doi: 10.36290/uro.2022.050.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Sihra N, Goodman A, Zakri R, et al. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 2018;15(12):750-776. doi: 10.1038/s41585-018-0106-x. Go to original source... Go to PubMed...
    2. Kotolová H. Probiotika a bakteriální lyzáty v podpůrné léčbě nekomplikovaných urologických infekcí. Urol. praxi. 2020;21(2):67-71. doi: 10.36290/uro.2020.025. Go to original source...
    3. Slíva J. Fixní kombinace hyaluronátu s chondroitin sulfátem u recidivujících cystitid, Urol. praxi. 2017;18(5):223-226. doi: 10.36290/uro.2017.052. Go to original source...
    4. Parsons CL, Boychuk D, Jones S, et al. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J. Urol. 1990;143:139-142. Go to original source... Go to PubMed...
    5. Parsons CL, Pollen JJ, Anwar H, et al. Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infect. Immun. 1980;27:876-881. Go to original source... Go to PubMed...
    6. Musilová H., Staněk R. Moderní trendy v profylaxi infekcí dolních cest močových. Urol. praxi. 2021;22(2):70-74. doi: 10.36290/uro.2021.022. Go to original source...
    7. Goddard JC, Janssen DAW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. Int Urogynecol J. 2018;29(7):933-942. doi: 10.1007/s00192-017-3508-z. Go to original source... Go to PubMed...
    8. Klečka J. Hyaluronát sodný - prevence a léčba urologické toxicity při onkologické terapii. Urol. praxi. 2021;22(4):181-184. doi: 10.36290/uro.2021.037. Go to original source...
    9. Soukop J, Večeřa R. Vybrané polyfenolické látky a jejich použití jako podpůrná terapie metabolického syndromu. Čes. slov. Farm. 2022;71:137-141. Go to original source...
    10. Arky Jane Langstieh JBW, Jane Lyngdoh C, et al. Estimation of quercetin and rutin content in hyouttunia cordata and Centella asiatica plant extracts using UV-spectrophotometer. Int. J. Pharm. Sci. Rev. Res. 2021;71(2):130-132. doi: 10.47583/ijpsrr.2021.v71i02.021. Go to original source...
    11. Chen YQ, Chen HY, Tang QQ, et al. Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines. Front Pharmacol. 2022;13:968226. doi: 10.3389/fphar.2022.968226. Go to original source... Go to PubMed...
    12. Batiha GE-S, Beshbishy AM, Ikram M, et al. The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin. Foods. 2020;9(3):374. doi.org/10.3390/foods9030374. Go to original source... Go to PubMed...
    13. Cosentino V, Fratter A, Cosentino M. Anti-inflammatory effects exerted by Killox®, an innovative formulation of food supplement with curcumin, in urology. Eur Rev Med Pharmacol Sci. 2016;20(7):1390-8. PMID: 27097964. Go to PubMed...
    14. Kučerová J, Kotolová H. Toxicita barviv používaných v léčivých přípravcích. Klin Farmakol Farm. 2013;27(1):41-47.
    15. Tůmová L, Zatloukalová L. Kurkuma - terapeutické účinky a možné interakce. Prakt. Lékáren. 2010;6(4):209-211.
    16. Nejezchlebová H, Švechotová T, Ševelová S. Kurkumin - co už víme a co je nadějné. Prakt. Lékáren. 2021;17(3):e44-e52. doi: 10.36290/lek.2021.044. Go to original source...
    17. Teow SY, Liew K, Ali SA, et al. Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review. J Trop Med. 2016;2016:2853045. doi: 10.1155/2016/2853045. Go to original source... Go to PubMed...
    18. Schiavi MC, Porpora MG, Vena F, et al. Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment. Female Pelvic Med Reconstr Surg. 2019;25(4):309-312. doi: 10.1097/SPV.0000000000000560. Go to original source... Go to PubMed...
    19. Torella M, Del Deo F, Grimaldi A, et al. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2016;207:125-128. doi: 10.1016/j.ejogrb.2016.10.018. Go to original source... Go to PubMed...
    20. Manfredi C, Spirito L, Calace FP, et al. Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril® Soft Gels) for the Prevention of LUTS after Intravesical Chemotherapy. Pathophysiology. 2022;29(3):365-373. doi: 10.3390/pathophysiology29030028. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.